Medication Rationality in Fever Clinics in A Hospital from January 2019 to June 2022

YU Dandan; CUI Jing; CHEN Wenqian; ZHANG Cuicui; LI Pengmei

doi:10.14009/j.issn.1672-2124.2023.02.023

您当前的位置：

首页 >

文章列表页 >

Medication Rationality in Fever Clinics in A Hospital from January 2019 to June 2022

更新时间：2023-04-14

- Medication Rationality in Fever Clinics in A Hospital from January 2019 to June 2022
- Issue 2, Pages: 237-240(2023)
- 作者机构：
  
  中日友好医院药学部
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2023.02.023
  CLC： R969.3
- Published：2023，
扫描看全文
YU Dandan, CUI Jing, CHEN Wenqian, et al. Medication Rationality in Fever Clinics in A Hospital from January 2019 to June 2022. [J]. (2):237-240(2023)
DOI：

YU Dandan, CUI Jing, CHEN Wenqian, et al. Medication Rationality in Fever Clinics in A Hospital from January 2019 to June 2022. [J]. (2):237-240(2023) DOI： 10.14009/j.issn.1672-2124.2023.02.023.

摘要

目的：了解2019年1月至2022年6月该院发热门诊药品使用量等方面的变化，对常用药品应用情况及趋势进行客观评价，为临床合理用药提供参考。方法：利用医院信息系统，回顾性统计2019年1月至2022年6月该院发热门诊常用药品及患者处方的相关数据，对常用药品的年销售量、年销售金额、用药频度（DDDs）及联合用药情况进行统计分析。结果：2019年1月至2022年6月该院发热门诊使用的药品中，口服西药中洛索洛芬钠片、左氧氟沙星片和对乙酰氨基酚缓释片用量较多，口服中成药中蓝芩口服液、金花清感颗粒和苏黄止咳胶囊用量较多；注射剂中，注射用头孢曲松用量最多，注射用头孢曲松与DDDs排序居前3位的西药联合应用情况远多于其与DDDs排序居前3位的中成药联合应用。各年龄段使用注射用头孢曲松的患者中，2020年和2021年随着年龄的增加，注射用头孢曲松与DDDs排序居前3位的西药联合应用占比逐渐升高；2022年1—6月，60～＜75岁使用注射用头孢曲松的患者中，注射用头孢曲松与DDDs排序居前3位的西药联合应用占比最高。各年龄段使用注射用头孢曲松的患者中，＜45岁患者中注射用头孢曲松与DDDs排序居前3位的中成药联合应用占比最高；随着年龄的增加，上述联合用药的占比逐渐降低。结论：该院发热门诊注射用头孢曲松与西药的联合应用基本合理，符合安全、有效、经济的用药原则。但注射用头孢曲松与中成药的联合应用情况并不理想，建议临床医师在药物治疗的过程中合理地联合使用药物，保证患者用药安全。

Abstract

OBJECTIVE: To investigate the changes of drug usage in fever clinics of the hospital from Jan. 2019 to Jun. 2022

and to perform objective evaluation on the application situation and trend of common drugs

so as to provide reference for clinical rational medication. METHODS: Data related to commonly used drugs and patient prescriptions in fever clinics of the hospital from Jan. 2019 to Jun. 2022 were retrospectively collected by using the hospital information system

which was analyzed in terms of annual sales amount

annual consumption sum

defined daily dose system（DDDs） and drug combination. RESULTS: Among the drugs used in fever clinics of the hospital from Jan. 2019 to Jun. 2022

the dosage of oral western medicine was higher for Loxoprofen sodium tablets

Levofloxacin tablets and Acetaminophen sustained release tablets

the dosage of oral Chinese patent medicine was higher for Lanqin oral liquid

Jinhua Qinggan granules and Suhuang Zhike capsules; as for injections

the dosage of ceftriaxone for injection the most

and the top three DDDs of western medicine in drug combination with ceftriaxone for injection was much more than the top three DDDs of Chinese patent medicine in drug combination. Among the patients who used ceftriaxone for injection at different ages

the proportion of combined use of ceftriaxone for injection and top 3 western drugs ranked by DDDs gradually increased with the increase of age in 2020 and 2021; from Jan. to Jun. 2022

among the patients aged 60 to <75 who used ceftriaxone for injection

the combination of ceftriaxone for injection and top 3 western drugs ranked by DDDs accounted for the highest proportion. Among the patients who used ceftriaxone for injection at different ages

the proportion of the combination of ceftriaxone for injection and top 3 Chinese patent medicine ranked by DDDs was the highest among the patients <45 years old; with the increase of age

the proportion of the above combined drugs gradually decreased. CONCLUSIONS: The combined application of ceftriaxone for injection with western medicine in department of fever clinic in this hospital is basically reasonable

which is in line with the medication principles of safe

effective and economical efficiency. However

the combined application of ceftriaxone for injection with Chinese patent medicine was unsatisfactory

and it is suggested that clinicians should reasonably combine drugs in the process of treatment to ensure medication safety for patients.

关键词

发热门诊合理用药头孢曲松联合用药

Keywords

Fever clinicRational medicationCeftriaxoneDrug combination

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Blood Concentration Monitoring of Digoxin in A Hospital and Its Influencing Factors

Special Review and Analysis on 68 211 Prescriptions of Danhong Injection

Application of Traditional Chinese Medicine Containing Tripterygii Radix in 510 Outpatient Prescriptions

Progress of Oxycodone Hydrochloride Combined with Other Drugs of Postoperative Patient-Controlled Analgesia

Effects of Prescription Pre-Review on Application of Nonsteroidal Anti-Inflammatory Drug After Orthopedic Surgery

Related Author

ZHANG Lili

YUAN Hailong

YANG Zhihui

ZHAO Yan

HUANG Jinghui

YANG Ming

ZHENG Peiyong

LIU Yishu

Related Institution

Dept.of Pharmacy, Air Force General Hospital of PLA

Phase Ⅰ Clinical Laboratory,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Dept.of Pharmacy,The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine

Dept.of Pharmacy,Dongfeng Hospital Affiliated to Hubei University of Medicine

Dept.of Pharmacy, Renmin Hospital of Wuhan University

⁰